Litigation Release No. 15683 / March 25, 1998

          SECURITIES AND EXCHANGE COMMISSION v. DAVID A. COLVIN; INTELLINET
          PUBLISHING, INC.; INTELLINET HOLDING GROUP, INC.; MEDICAL
          ADVANTAGE, INC.; LAMELLI, INC., a/k/a LAMELLI MEDICAL TECHNOLOGY,
          INC.; WALL STREET RESEARCH COMPANY, INC.; JOB KJELL HOVIK; LAMAR
          ELLIS; and JOHN LARSON, a/k/a  JOHN ST. JOHN, Civil Action No.
          SACV 98-135 AHS (EEx) (C.D. Cal.)

          On March 16, 1998, the Honorable Alicemarie H. Stotler, United
          States District Judge for the Central District of California,
          issued an order of preliminary injunction against defendants
          David A. Colvin, Job Kjell Hovik; Intellinet Publishing, Inc.;
          Intellinet Holding Group, Inc.; Medical Advantage, Inc.; Lamelli,
          Inc. a/k/a Lamelli Medical Technology, Inc.; and Wall Street
          Research Company, Inc.  The Court also ordered appointment of a
          permanent receiver over the entity Defendants and continued a
          previous order freezing these Defendants' assets and prohibiting
          the destruction of documents. Also, on March 16, 1998, the Court
          entered a Final Judgment Of Permanent Injunction And Other Relief
          Against Defendant Lamar Ellis.  The judgment, which Defendant
          Ellis consented to, without admitting or denying the Commission's
          allegations, permanently enjoins him from future violations of
          Section 17(a) of the Securities Act of 1933 and Section 10(b) of
          the Securities Exchange Act of 1934 and Rule 10b-5 thereunder.
          On March 2, 1998, the Court had issued an order of preliminary
          injunction against Defendant John Larson a/k/a John St. John.

          The preliminary injunction orders enjoin the Defendants from
          future violations of the registration, antifraud and broker-
          dealer registration provisions of Sections 5(a), 5(c) and 17(a)
          of the Securities Act of 1933 and Sections 10(b) and 15(a) of
          Securities Exchange Act of 1934 and Rule 10b-5 thereunder.

          The Commission's Complaint, filed on February 19, 1998, alleges
          that the Defendants raised over $5 million since January 1997,
          defrauding investors, by among other things, falsely representing
          that former U.S. Surgeon General C. Everett Koop and NBC
          television journalist Tom Brokaw were affiliated with Defendant
          Medical Advantage, Inc., a company which purportedly operated
          obesity clinics but which was, in fact, insolvent and which the
          Defendants falsely claimed was the subject of an imminent public
          stock offering.  The Commission further alleges that investors
          were falsely promised the return of their principal investment,
          plus 12% interest, in 120 to 180 days.  Instead, Defendants
          Colvin and Hovik misappropriated investor funds, using most of
          the money for boiler room expenses and for other business
          ventures.  Among the other misrepresentations alleged, the
          Defendants falsely claimed that Defendants Intellinet and Lamelli
          would also be the subject of an imminent public stock offering.

          For additional information, see Litigation Release No. 15651
          (February 24, 1998).

          PERSON TO CONTACT:
          Karen Matteson
          Pacific Regional Office/Los Angeles
          (213) 965-3840